CELC vs POOL Comparison

Celcuity Inc is a clinical-stage biotechnology company developing targeted therapies for multiple solid tumors. Its candidate, gedatolisib, is a kinase inhibitor of the PI3K/AKT/mTOR (PAM) pathway, binding all class I PI3K isoforms and mTORC1/2, offering comprehensive inhibition with a mechanism and pharmacokinetics differentiated from other therapies. The Phase 3 VIKTORIA-1 trial, evaluating gedatolisib with fulvestrant, with or without palbociclib, in HR+/HER2- breast cancer, has completed enrollment and reported results for PIK3CA WT tumors, with cohort 2 (PIK3CA MT) also enrolled. Phase 3 VIKTORIA-2 and Phase 1b/2 CELC-G-201 trials, evaluating combinations in endocrine-resistant HR+/HER2- breast cancer and metastatic castration-resistant prostate cancer, are ongoing.

Pool Corp is a wholesale distributor of swimming pool supplies, equipment, and related leisure products. The company's products include pool pumps, filters, heaters, and cleaners; pool maintenance products like chemicals, supplies, and repair parts; irrigation and landscape maintenance products; and outdoor lighting, grills, outdoor kitchen components, etc. These products are offered through branded distribution networks such as Horizon, SCP, Poolcorp Commercial Aquatics, Sun Wholesale Supply, Superior Pool Products, and NPT. The company's customers include pool builders, pool service companies, retail stores, commercial pool operators, and landscape contractors. Geographically, it generates maximum revenue from the United States, followed by other markets like Europe and Australia.